Back To Search Instructions
Protocols
7 protocol(s) meet the specified criteria
Age Group: A
Keyword: Neuroendocrine
Protocol No.TitleStatus
165511Targeting Adaptive Pathways in Abiraterone and Enzalutamide Refractory Intermediate Atypical CarcinomaOpen
169524A Pilot Study of Pembrolizumab-based Therapy in Previously Treated High Grade Neuroendocrine CarcinomasOpen
17459Randomized Embolization Trial for NeuroEndocrine Tumor Metastases To The Liver (RETNET): A phase 2 randomized multicenter trial to compare hepatic progression-free survival following bland embolization, lipiodol chemoembolization, and drug-eluting bead chemoembolization of neuroendocrine liver metastasesOpen
17705A pilot study of pembrolizumab and liver-directed therapy for patients with well-differentiated neuroendocrine tumors and symptomatic and/or progressive liver metastases Open
18954A PHASE 1 STUDY OF FOR46 ADMINISTERED EVERY 21 DAYS IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (MCRPC)Open
19551A Phase 1b/2 Study of BXCL701, a Small Molecule Inhibitor of Dipeptidyl Peptidases (DPP), Administered in Combination with the Anti-Programmed Cell Death 1 (PD-1) Monoclonal Antibody Pembrolizumab (PEMBRO; Keytruda) in Patients with Small Cell Neuroendocrine Prostate Cancer (SCNC; NEPC)Open
ALLIANCE-A021602RANDOMIZED, DOUBLE-BLINDED PHASE III STUDY OF CABOZANTINIB VERSUS PLACEBO IN PATIENTS WITH ADVANCED NEUROENDOCRINE TUMORS AFTER PROGRESSION ON EVEROLIMUS (CABINET)Open